MedPath

河北巨龙药业有限责任公司

Ownership
-
Established
1999-06-04
Employees
-
Market Cap
-
Website
http://www.hbjiyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

76

NMPA:76

Drug Approvals

理中丸

Approval Number
国药准字Z13021295
Approval Date
Oct 27, 2020
NMPA

加味藿香正气丸

Approval Number
国药准字Z13021293
Approval Date
Oct 27, 2020
NMPA

开胸顺气丸

Approval Number
国药准字Z20026489
Approval Date
Oct 27, 2020
NMPA

补中益气丸

Approval Number
国药准字Z13021836
Approval Date
Oct 27, 2020
NMPA

槟榔四消丸

Approval Number
国药准字Z13021303
Approval Date
Oct 27, 2020
NMPA

清眩丸

Approval Number
国药准字Z13020187
Approval Date
Oct 18, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H13022445
Approval Date
Oct 18, 2020
NMPA

Compound Paracetamol and Chlorphenamine Maleate Granules

Product Name
复方氨酚那敏颗粒
Approval Number
国药准字H13023263
Approval Date
Oct 18, 2020
NMPA

Cinnarizine Tablets

Product Name
桂利嗪片
Approval Number
国药准字H13020448
Approval Date
Oct 18, 2020
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H13023261
Approval Date
Oct 18, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.